The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infectionsThomas Tängdén, Jason A. Roberts, Véronique Martin et al.|Intensive Care Medicine|2017Cited by 149
A novel mechanism-based pharmacokinetic–pharmacodynamic (PKPD) model describing ceftazidime/avibactam efficacy against β-lactamase-producing Gram-negative bacteriaAnders Kristoffersson, Elisabet I. Nielsen, Isabelle Walter et al.|Journal of Antimicrobial Chemotherapy|2019Cited by 18